UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity

Journal of antimicrobial chemotherapy, 2010-11, Vol.65 (suppl-4), p.iv9-iv16

2010

Volltextzugriff (PDF)

Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3612-3616

2007

Volltextzugriff (PDF)

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.258-270

2012

Volltextzugriff (PDF)

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2231-2236

2012

Volltextzugriff (PDF)

Review of ceftaroline fosamil microbiology: integrated FOCUS studies

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 Suppl 3 (Supplement 3), p.iii45-iii51

2011

Volltextzugriff (PDF)

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Prospective Study of the Wilson Severity-of-Illness Scoring System for Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.647-650

2013

Volltextzugriff (PDF)

Efficacy of Ceftaroline Fosamil for Bacteremia Associated With Community-Acquired Bacterial Pneumonia

Hospital Practice, 2014-02, Vol.42 (1), p.75-78

2014

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV

Blood, 2016-12, Vol.128 (22), p.2197-2197

2016

Volltextzugriff (PDF)

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection

Clinical infectious diseases, 2010-09, Vol.51 (6), p.641-650

2010

Volltextzugriff (PDF)

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled-Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community-Acquired Pneumonia

Clinical infectious diseases, 2010-12, Vol.51 (12), p.1395-1405

2010

Volltextzugriff (PDF)

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 Suppl 3 (suppl_3), p.iii33-iii44

2011

Volltextzugriff (PDF)

Review of ceftaroline fosamil microbiology: integrated FOCUS studies: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil

Journal of antimicrobial chemotherapy, 2011, Vol.66

2011

Volltextzugriff (PDF)

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections: A new option for complicated skin and skin structure infections: experience with ceftaroline

Journal of antimicrobial chemotherapy, 2010, Vol.65

2010

Volltextzugriff (PDF)

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections: A new option for complicated skin and skin structure infections: experience with ceftaroline

Journal of antimicrobial chemotherapy, 2010, Vol.65

2010

Volltextzugriff (PDF)

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity: A new option for complicated skin and skin structure infections: experience with ceftaroline

Journal of antimicrobial chemotherapy, 2010, Vol.65

2010

Volltextzugriff (PDF)

PK-PD Target Attainment Analyses to Support the Selection of Extended Interval CD101 Dosing Regimens

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil

Journal of antimicrobial chemotherapy, 2011, Vol.66

2011

Volltextzugriff (PDF)

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil

Journal of antimicrobial chemotherapy, 2011, Vol.66

2011

Volltextzugriff (PDF)

Transforming growth factor-β, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells

Journal of cellular physiology, 1996-08, Vol.168 (2), p.433-441

1996

Volltextzugriff (PDF)

The isolation of a fibroblast growth inhibitor associated with perigraft seroma

Journal of vascular surgery, 1994-08, Vol.20 (2), p.202-208

1994

Volltextzugriff (PDF)

Applicability of the IEC 61000-4-20 for transient testing with UWB signals

2008 International Symposium on Electromagnetic Compatibility - EMC Europe, 2008, p.1-5

2008

Volltextzugriff (PDF)

Aspects of using the IEC 61000-4-20 for transient testing with broadband signals

2008 IEEE International Symposium on Electromagnetic Compatibility, 2008, p.1-5

2008

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(22)
Tagungsberichte
(2)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(13)
Medical Sciences
(13)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)
Humans
(12)
Life Sciences & Biomedicine
(12)
Pharmacology. Drug Treatments
(12)
Science & Technology
(12)
Infectious Diseases
(10)
Microbiology
(10)
Ceftaroline
(9)
Female
(8)
Male
(8)
Middle Aged
(8)
Pharmacology & Pharmacy
(8)
Treatment Outcome
(8)
Aged
(6)
Clinical Trials
(6)
Adult
(5)
Anti-Bacterial Agents - Therapeutic Use
(5)
Bacterial Diseases
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity

Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

Review of ceftaroline fosamil microbiology: integrated FOCUS studies

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults

Prospective Study of the Wilson Severity-of-Illness Scoring System for Complicated Skin and Skin Structure Infections

Efficacy of Ceftaroline Fosamil for Bacteremia Associated With Community-Acquired Bacterial Pneumonia

Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV

Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled-Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community-Acquired Pneumonia

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Review of ceftaroline fosamil microbiology: integrated FOCUS studies: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections: A new option for complicated skin and skin structure infections: experience with ceftaroline

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections: A new option for complicated skin and skin structure infections: experience with ceftaroline

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity: A new option for complicated skin and skin structure infections: experience with ceftaroline

PK-PD Target Attainment Analyses to Support the Selection of Extended Interval CD101 Dosing Regimens

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia: Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil

Transforming growth factor-β, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells

The isolation of a fibroblast growth inhibitor associated with perigraft seroma

Applicability of the IEC 61000-4-20 for transient testing with UWB signals

Aspects of using the IEC 61000-4-20 for transient testing with broadband signals

Suchergebnisse filtern